Eli Lilly and Company (LLY)

$903.02 -7.53 (-0.83%)
Market Cap 860.30B
Revenue (ttm) 65.18B
Net Income (ttm) 20.64B
EPS (ttm) N/A
PE Ratio 37.45
Forward PE 26.10
Profit Margin 31.67%
Debt to Equity Ratio 1.54
Volume 2,572,600
Avg Vol 3,209,576
Day's Range N/A - N/A
Shares Out 944.82M
Stochastic %K 7%
Beta 0.40
Analysts Strong Sell
Price Target $1,235.07

Company Profile

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, including Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 317 276 2000
Address:
Lilly Corporate Center, Indianapolis, United States
Srinivas111
Srinivas111 Mar. 25 at 10:20 AM
$LLY yime to buy
0 · Reply
Yatish82
Yatish82 Mar. 25 at 6:12 AM
$LLY way oversold rsi 30 and stochastic rsi is 0.005 extremely oversold All analyst is having buy rating.accept one idiot, any approval news for oral and it blast .twice touch the 200sma and i am expecting hard bounce.
2 · Reply
DynamicWatch
DynamicWatch Mar. 25 at 5:41 AM
$LLY strong healthcare name, just keeping an eye.
0 · Reply
Jaxson25
Jaxson25 Mar. 25 at 4:21 AM
$LLY 600 incoming again retrace
1 · Reply
mikesterz7
mikesterz7 Mar. 25 at 1:56 AM
$LLY Barclays reaffirmed its ‘Overweight’ rating on the LLY stock and its $1,350 price target.
0 · Reply
AllAboutTheBread
AllAboutTheBread Mar. 25 at 12:33 AM
$LLY bout to rip everyones face off.
0 · Reply
SuperSuper
SuperSuper Mar. 25 at 12:19 AM
$ALT $NVO $LLY $VKTX Game over! https://sereneexpedition.com/burnsl/cb/vsl/l2ml01/?hopId=93260cf9-f50e-4f3a-a4ac-d996b254a48f&affiliate=rubyhill&tid=552b9e8993d44d7b8f7b1caddfbe492e
0 · Reply
ndgt10
ndgt10 Mar. 25 at 12:15 AM
$LLY Has a date with the 200DMA
0 · Reply
TradeTracs
TradeTracs Mar. 24 at 7:50 PM
This ones giving me $LLY vibez on the monthly view. Here we have $JAZZ daily, with a snippet of its weekly. -Tight post earnings base with drying volume -Weekly just peaked above a triple inside candle stack -Digested November earnings & gave almost nothing back -Riding 5ema weekly to a T💎 Lets see how this one goes📈 (PS: yes it may breakout, but what we're looking for here is accompanied VOL surge for proper confirmation)
0 · Reply
Makingmillions192
Makingmillions192 Mar. 24 at 7:21 PM
$LEXX The trend is your friend and we have powerful bullish signals from the daily, weekly, and monthly candles. All of them are suggesting we are now in an up trend. Multinational Talks: Lexaria transitioned from "searching" to "negotiating," explicitly confirming active discussions with several multinational pharmaceutical companies. The April 30th Deadline: The MTA expiration, Eli Lilly’s oral approval, and Sun’s generic rollout all converge next month. Lexaria is the key to this "once-in-a-lifetime" window. $LLY $NVO $JAZZ $TEVA
0 · Reply
Latest News on LLY
What's Going On With Eli Lilly On Monday?

Mar 23, 2026, 1:20 PM EDT - 1 day ago

What's Going On With Eli Lilly On Monday?

U.S. executives, from Apple to Eli Lilly, revamp their push into the world's second-largest economy at the China Development Forum

Mar 23, 2026, 10:05 AM EDT - 1 day ago

U.S. executives, from Apple to Eli Lilly, revamp their push into the world's second-largest economy at the China Development Forum

AAPL

Our Top 10 High Growth Dividend Stocks - March 2026

Mar 21, 2026, 8:15 AM EDT - 3 days ago

Our Top 10 High Growth Dividend Stocks - March 2026

APH AU CCJ CIB COKE CVE FIX

Why Eli Lilly Remains My Top Obesity Bet

Mar 20, 2026, 1:38 PM EDT - 4 days ago

Why Eli Lilly Remains My Top Obesity Bet

Eli Lilly's next-generation obesity drug retatrutide clears first late-stage diabetes trial

Mar 19, 2026, 6:45 AM EDT - 5 days ago

Eli Lilly's next-generation obesity drug retatrutide clears first late-stage diabetes trial

Lilly's triple agonist, retatrutide, demonstrated significant reductions in A1C and weight in first Phase 3 trial for treatment of type 2 diabetes

Mar 19, 2026, 6:45 AM EDT - 5 days ago

Lilly's triple agonist, retatrutide, demonstrated significant reductions in A1C and weight in first Phase 3 trial for treatment of type 2 diabetes

TrumpRx lists many medicines at prices higher than paid in UK

Mar 18, 2026, 2:23 PM EDT - 6 days ago

TrumpRx lists many medicines at prices higher than paid in UK

ABBV AMGN AZN BMY GILD GSK JNJ

Healthy Returns: Stopping GLP-1s raises risk of heart attack, stroke and death, study says

Mar 18, 2026, 2:06 PM EDT - 6 days ago

Healthy Returns: Stopping GLP-1s raises risk of heart attack, stroke and death, study says

NVO

Roche Vs. Eli Lilly: Nvidia Deals, Obesity Battles Stoke Rivalry (I'd Buy Both)

Mar 18, 2026, 1:57 PM EDT - 6 days ago

Roche Vs. Eli Lilly: Nvidia Deals, Obesity Battles Stoke Rivalry (I'd Buy Both)

Stock Of The Day: Is The Eli Lilly Selloff Over?

Mar 18, 2026, 1:30 PM EDT - 6 days ago

Stock Of The Day: Is The Eli Lilly Selloff Over?

Lilly gets rare downgrade as analysts question hype over GLP-1 pills and Zepbound's cash sales

Mar 17, 2026, 2:28 PM EDT - 7 days ago

Lilly gets rare downgrade as analysts question hype over GLP-1 pills and Zepbound's cash sales

Eli Lilly Analyst Flags Overhyped Obesity Drug Expectations

Mar 17, 2026, 12:57 PM EDT - 7 days ago

Eli Lilly Analyst Flags Overhyped Obesity Drug Expectations

4 Stocks To Buy While Everyone Else Doubts AI

Mar 17, 2026, 12:25 PM EDT - 7 days ago

4 Stocks To Buy While Everyone Else Doubts AI

MU NFLX NVDA

Eli Lilly falls after a 6 month rally; is this a buy the dip opportunity?

Mar 17, 2026, 11:42 AM EDT - 7 days ago

Eli Lilly falls after a 6 month rally; is this a buy the dip opportunity?

Eli Lilly Stock Gets Downgraded. It Faces Stiff Headwinds After Strong Run-Up.

Mar 17, 2026, 10:04 AM EDT - 7 days ago

Eli Lilly Stock Gets Downgraded. It Faces Stiff Headwinds After Strong Run-Up.

Tuesday's Morning Movers: DAL Lifts Guidance, LLY & DKNG Downgrades

Mar 17, 2026, 10:02 AM EDT - 7 days ago

Tuesday's Morning Movers: DAL Lifts Guidance, LLY & DKNG Downgrades

DKNG DAL

Lilly's EBGLYSS (lebrikizumab-lbkz) is the first and only selective IL-13 inhibitor to deliver positive Phase 3 outcomes in patients aged six months to 18 years with moderate-to-severe atopic dermatitis

Mar 16, 2026, 6:45 AM EDT - 8 days ago

Lilly's EBGLYSS (lebrikizumab-lbkz) is the first and only selective IL-13 inhibitor to deliver positive Phase 3 outcomes in patients aged six months to 18 years with moderate-to-severe atopic dermatitis

Invesco Rising Dividends Fund Q4 2025 Portfolio Activity

Mar 13, 2026, 12:23 PM EDT - 11 days ago

Invesco Rising Dividends Fund Q4 2025 Portfolio Activity

AAPL ABT AVGO ETN GOOGL LIN META

Using Obesity Drug? Eli Lilly Flags Unknown Impurity Found In Compounded Weight Loss Drugs With Vitamin B12

Mar 12, 2026, 2:04 PM EDT - 12 days ago

Using Obesity Drug? Eli Lilly Flags Unknown Impurity Found In Compounded Weight Loss Drugs With Vitamin B12

Eli Lilly: The Weight-Loss Craze Isn't Over

Mar 12, 2026, 6:54 AM EDT - 12 days ago

Eli Lilly: The Weight-Loss Craze Isn't Over

Eli Lilly Could Rejoin Abivax Bidding If AstraZeneca Misses Deadline

Mar 12, 2026, 6:46 AM EDT - 12 days ago

Eli Lilly Could Rejoin Abivax Bidding If AstraZeneca Misses Deadline

ABVX

Lilly finds impurity in compounded version of its weight-loss drug, warns of health risks

Mar 12, 2026, 5:01 AM EDT - 13 days ago

Lilly finds impurity in compounded version of its weight-loss drug, warns of health risks

India warns drugmakers against direct or surrogate weight-loss drug and obesity ads

Mar 11, 2026, 3:26 PM EDT - 13 days ago

India warns drugmakers against direct or surrogate weight-loss drug and obesity ads

NVO

Goldman Sachs Large Cap Equity Fund Q4 2025 Portfolio Activity

Mar 11, 2026, 9:36 AM EDT - 13 days ago

Goldman Sachs Large Cap Equity Fund Q4 2025 Portfolio Activity

AMD APD CAT DHI FISV JNJ

Harbor Health Care ETF Q4 2025 Portfolio Review

Mar 11, 2026, 8:18 AM EDT - 13 days ago

Harbor Health Care ETF Q4 2025 Portfolio Review

ABBV ABVX GMAB MASI MEDI MRK RVMD

Health Rounds: Death from dementia on the rise among people with type 2 diabetes

Mar 11, 2026, 7:28 AM EDT - 13 days ago

Health Rounds: Death from dementia on the rise among people with type 2 diabetes

AZN NVO

Eli Lilly to invest $3 billion in China over next decade

Mar 11, 2026, 5:13 AM EDT - 14 days ago

Eli Lilly to invest $3 billion in China over next decade

Is Lilly Stock Still The Best Growth Story In Healthcare?

Mar 10, 2026, 1:20 PM EDT - 14 days ago

Is Lilly Stock Still The Best Growth Story In Healthcare?

Virtus Large Cap Growth SMA Q4 2025 Portfolio Review

Mar 9, 2026, 3:21 PM EDT - 15 days ago

Virtus Large Cap Growth SMA Q4 2025 Portfolio Review

BMY GOOG ORLY RCL GOOGL

Eli Lilly says some Medicare plans may exceed $50 cap for weight-loss drugs

Mar 9, 2026, 10:52 AM EDT - 15 days ago

Eli Lilly says some Medicare plans may exceed $50 cap for weight-loss drugs

Wall Street Breakfast Podcast: India To Buy Russian Oil As War Disrupts Supplies

Mar 6, 2026, 6:05 AM EST - 18 days ago

Wall Street Breakfast Podcast: India To Buy Russian Oil As War Disrupts Supplies

AMD GOOG GOOGL NVDA NVO PFE

What Are The Biggest Risks To Eli Lilly Stock?

Mar 5, 2026, 10:25 AM EST - 19 days ago

What Are The Biggest Risks To Eli Lilly Stock?

Eli Lilly launches program to help boost employer coverage of obesity drugs in U.S.

Mar 5, 2026, 6:00 AM EST - 19 days ago

Eli Lilly launches program to help boost employer coverage of obesity drugs in U.S.

Lilly Employer Connect platform launches with over fifteen independent program administrators offering tailored obesity coverage options to expand access to patients

Mar 5, 2026, 6:00 AM EST - 19 days ago

Lilly Employer Connect platform launches with over fifteen independent program administrators offering tailored obesity coverage options to expand access to patients

GLP-1 drugs protect against new or worsening addictions, large study shows

Mar 4, 2026, 6:36 PM EST - 20 days ago

GLP-1 drugs protect against new or worsening addictions, large study shows

AZN NVO

Baron Health Care Fund Q4 2025 Contributors And Detractors

Mar 3, 2026, 10:18 AM EST - 21 days ago

Baron Health Care Fund Q4 2025 Contributors And Detractors

ACLX ARGX DOCS EHC INSM RDNT SYK

Eli Lilly and Company (LLY) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Mar 2, 2026, 5:57 PM EST - 22 days ago

Eli Lilly and Company (LLY) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Eli Lilly on track to launch oral obesity drug in second quarter, pending US approval

Mar 2, 2026, 3:58 PM EST - 22 days ago

Eli Lilly on track to launch oral obesity drug in second quarter, pending US approval

Why Eli Lilly is Winning the Weight Loss War

Feb 27, 2026, 12:30 PM EST - 25 days ago

Why Eli Lilly is Winning the Weight Loss War

Lilly's Olumiant (baricitinib) recommended by CHMP for approval of expanded use in the European Union for adolescents with severe alopecia areata

Feb 27, 2026, 8:11 AM EST - 25 days ago

Lilly's Olumiant (baricitinib) recommended by CHMP for approval of expanded use in the European Union for adolescents with severe alopecia areata

INCY

Eli Lilly reports additional data on weight-loss pill from diabetes trial

Feb 26, 2026, 6:32 AM EST - 26 days ago

Eli Lilly reports additional data on weight-loss pill from diabetes trial

Lilly's oral GLP-1, orforglipron, delivered superior blood sugar control and weight loss compared to oral semaglutide in head-to-head type 2 diabetes trial published in The Lancet

Feb 26, 2026, 6:30 AM EST - 26 days ago

Lilly's oral GLP-1, orforglipron, delivered superior blood sugar control and weight loss compared to oral semaglutide in head-to-head type 2 diabetes trial published in The Lancet

Columbia Balanced Fund Q4 2025 Contributors And Detractors

Feb 25, 2026, 11:23 AM EST - 27 days ago

Columbia Balanced Fund Q4 2025 Contributors And Detractors

AMAT BLK GOOGL MSFT TMUS GOOG

Novo Nordisk and Eli Lilly shares both fall after Ozempic price-cut plan

Feb 24, 2026, 7:51 AM EST - 4 weeks ago

Novo Nordisk and Eli Lilly shares both fall after Ozempic price-cut plan

NVO

Novo's stumbles burnish Lilly's widening lead in weight-loss drugs

Feb 24, 2026, 12:09 AM EST - 4 weeks ago

Novo's stumbles burnish Lilly's widening lead in weight-loss drugs

NVO

Eli Lilly's Zepbound Gets FDA OK for Multi-Dose Pen

Feb 23, 2026, 12:06 PM EST - 4 weeks ago

Eli Lilly's Zepbound Gets FDA OK for Multi-Dose Pen

Novo Nordisk's Loss Is Eli Lilly's Gain

Feb 23, 2026, 11:42 AM EST - 4 weeks ago

Novo Nordisk's Loss Is Eli Lilly's Gain

NVO

Eli Lilly bets on multi-dose Zepbound pen in GLP-1 retention push

Feb 23, 2026, 9:41 AM EST - 4 weeks ago

Eli Lilly bets on multi-dose Zepbound pen in GLP-1 retention push

Eli Lilly launches new form of obesity drug Zepbound with a month's worth of doses in one pen

Feb 23, 2026, 9:00 AM EST - 4 weeks ago

Eli Lilly launches new form of obesity drug Zepbound with a month's worth of doses in one pen

Zepbound (tirzepatide), the most prescribed weight management medication in 2025, now available in multi-dose KwikPen

Feb 23, 2026, 9:00 AM EST - 4 weeks ago

Zepbound (tirzepatide), the most prescribed weight management medication in 2025, now available in multi-dose KwikPen

Srinivas111
Srinivas111 Mar. 25 at 10:20 AM
$LLY yime to buy
0 · Reply
Yatish82
Yatish82 Mar. 25 at 6:12 AM
$LLY way oversold rsi 30 and stochastic rsi is 0.005 extremely oversold All analyst is having buy rating.accept one idiot, any approval news for oral and it blast .twice touch the 200sma and i am expecting hard bounce.
2 · Reply
DynamicWatch
DynamicWatch Mar. 25 at 5:41 AM
$LLY strong healthcare name, just keeping an eye.
0 · Reply
Jaxson25
Jaxson25 Mar. 25 at 4:21 AM
$LLY 600 incoming again retrace
1 · Reply
mikesterz7
mikesterz7 Mar. 25 at 1:56 AM
$LLY Barclays reaffirmed its ‘Overweight’ rating on the LLY stock and its $1,350 price target.
0 · Reply
AllAboutTheBread
AllAboutTheBread Mar. 25 at 12:33 AM
$LLY bout to rip everyones face off.
0 · Reply
SuperSuper
SuperSuper Mar. 25 at 12:19 AM
$ALT $NVO $LLY $VKTX Game over! https://sereneexpedition.com/burnsl/cb/vsl/l2ml01/?hopId=93260cf9-f50e-4f3a-a4ac-d996b254a48f&affiliate=rubyhill&tid=552b9e8993d44d7b8f7b1caddfbe492e
0 · Reply
ndgt10
ndgt10 Mar. 25 at 12:15 AM
$LLY Has a date with the 200DMA
0 · Reply
TradeTracs
TradeTracs Mar. 24 at 7:50 PM
This ones giving me $LLY vibez on the monthly view. Here we have $JAZZ daily, with a snippet of its weekly. -Tight post earnings base with drying volume -Weekly just peaked above a triple inside candle stack -Digested November earnings & gave almost nothing back -Riding 5ema weekly to a T💎 Lets see how this one goes📈 (PS: yes it may breakout, but what we're looking for here is accompanied VOL surge for proper confirmation)
0 · Reply
Makingmillions192
Makingmillions192 Mar. 24 at 7:21 PM
$LEXX The trend is your friend and we have powerful bullish signals from the daily, weekly, and monthly candles. All of them are suggesting we are now in an up trend. Multinational Talks: Lexaria transitioned from "searching" to "negotiating," explicitly confirming active discussions with several multinational pharmaceutical companies. The April 30th Deadline: The MTA expiration, Eli Lilly’s oral approval, and Sun’s generic rollout all converge next month. Lexaria is the key to this "once-in-a-lifetime" window. $LLY $NVO $JAZZ $TEVA
0 · Reply
dnpro
dnpro Mar. 24 at 6:01 PM
$SDGR I read about rumors about big pharma to buy it. Do you read something about it? $PFE $LLY $QQQ
1 · Reply
StocktwitsNews
StocktwitsNews Mar. 24 at 5:58 PM
Eli Lilly’s Slump Drags LLY Shares To 200-DMA For First Time In 5 Months — Barclays Says Stock Too Cheap To Ignore $LLY https://stocktwits.com/news/equity/markets/eli-lilly-lly-stock-200dma-barclays-rating/cZ3np39RI1L
0 · Reply
DonCorleone77
DonCorleone77 Mar. 24 at 4:17 PM
$LLY Attached is a Barclays analyst note regarding LLY issued today.
0 · Reply
DragonAlgo
DragonAlgo Mar. 24 at 4:14 PM
🐉 $LLY PUT — DragonAlgo® Signal Contract: LLY PUT Expiry: 2026-03-27 | Strike: $900.00 | Type: PUT Option Plan (premium): Entry: $11.82 Stop: $8.51 TP1: $15.37 TP2: $20.10 TP3: $28.38 🔗 https://dragonalgo.com
0 · Reply
Honeystocks
Honeystocks Mar. 24 at 2:39 PM
Buying $LLY right now probably needs to come with a financial health warning.... Are you buying here? $IBB $XBI $XLV
0 · Reply
Starrider111
Starrider111 Mar. 24 at 1:48 PM
Bought $LLY & Holding $MOS
1 · Reply
Yatish82
Yatish82 Mar. 24 at 11:28 AM
$LLY Barclay mantaij today buy rating with Tp 1350$
0 · Reply
Alpha_Ascendant
Alpha_Ascendant Mar. 24 at 11:17 AM
$DRTS $MRK $RVMD $LLY $BMY Alpha Tau Medical, an under-the-radar Israeli micro-cap, is quietly developing a significant breakthrough in oncology, delivering alpha particle radiation locally into solid tumors: https://seekingalpha.com/article/4885167-alpha-tau-medical-stock-2026-breakthrough-year
3 · Reply
Flabslab
Flabslab Mar. 24 at 10:22 AM
$LLY
0 · Reply
usenterprise
usenterprise Mar. 24 at 8:33 AM
$LLY Don't get caught on the wrong side of the trade: https://www.ksl.com/article/51456106/eli-lilly-on-track-to-launch-oral-obesity-drug-in-second-quarter-pending-us-approval
1 · Reply
chuckieclam
chuckieclam Mar. 24 at 6:30 AM
$NVO wow has this weird foreign mess been shithoused! and you kept buyin it ALL THE WAY DOWN , dincha? guess that HIMS AND HERS bullshit didnt work out too well, huh? 😂 at one time this "danish" company owned the GLP1 market with ozempic. boy did they blow it! never mess with the KING $LLY or you see what happens! something is rotten in denmark !!! 🥾 🥾😂 😂
0 · Reply
DragonAlgo
DragonAlgo Mar. 24 at 12:49 AM
🐉 $LLY PUT — DragonAlgo® Signal Contract: LLY PUT Expiry: 2026-03-27 | Strike: $910.00 | Type: PUT Option Plan (premium): Entry: $14.68 Stop: $10.57 TP1: $19.08 TP2: $24.95 TP3: $35.22 🔗 https://dragonalgo.com
0 · Reply